Stay
up-to-date
about
RECOVER
Our understanding of Long COVID is constantly evolving with new research findings. Stay informed by reading the latest news and participating in upcoming events.
During the April 8th RECOVER Research Review (R3) Seminar, RECOVER researchers Hannah Mandel, MS, Fei Wang, PhD, Sandy Preiss, MS, and Abhishek Bhatia, MS presented findings from two different studies of electronic health records (EHRs). Rainu Kaushal, MD (Cornell University), Dr. Wang’s co-author, joined the presenters for the panel discussion and audience Q&A. Both studies examined whether taking the antiviral drug Paxlovid during a COVID-19 infection could help prevent Long COVID. Although Paxlovid is known to reduce the risk of severe COVID-19, there has been limited research into how Paxlovid might impact a person’s risk of developing Long COVID. The studies presented are two of the largest to date that have explored the role of Paxlovid in Long COVID prevention.
Patient, Caregiver, and Community Representatives inform RECOVER research, help connect the initiative with different communities, and share news about RECOVER studies.
During the March 11th RECOVER Research Review (R3) Seminar, RECOVER researchers shared findings from a recent study that examined how a person’s sex may affect their risk of developing Long COVID. Dimpy Shah, MD, PhD (University of Texas Health Science Center) presented results from the study, and Nora Singer, MD (Case Western Reserve University, MetroHealth Medical Center) shared background about RECOVER’s adult observational study population and ideas for future research in this area.
During the February 11th RECOVER Research Review (R3) Seminar, Dr. Grace McComsey (Case Western Reserve University) and Dr. Kristine Erlandson (University of Colorado Anschutz Medical Campus) discussed how biomarkers – signs of disease that can be observed and measured – may provide information that will improve researchers’ ability to understand, diagnose, prevent, and treat Long COVID. Dr. McComsey and Dr. Linda Geng (Stanford University) also discussed recent updates to and findings from the RECOVER-Adult Long COVID Research Index.
A recent RECOVER study found that women had a 31% higher risk for developing Long COVID than men. Findings from this study may help identify who is at a higher risk for developing Long COVID and potential Long COVID treatments.
Over the last two years, RECOVER Patient, Caregiver, and Community Representatives have helped plan and write more than 100 publications about RECOVER’s Long COVID research and its findings.
RECOVER research continues to advance our understanding of how and why Long COVID can affect everyone differently.
During the January 28th RECOVER Research Review (R3) Seminar, Dr. Kellie Owens, PhD (NYU Grossman School of Medicine) shared ethical guidance for enrolling individuals in clinical studies who have direct involvement with the research. Dr. Owens was joined by co-authors Leah Castro, MA (RECOVER Community and Caregiver Representative) and Rebecca Letts (RECOVER Patient and Caregiver Representative), who described Representatives’ important role in designing RECOVER clinical studies and developing peer-reviewed research publications.
RECOVER researchers found that people were more likely to develop myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) after having COVID-19. Most of the people who developed ME/CFS also developed Long COVID.
Media InquiriesAre you a member of the media or press? Please direct inquiries to the RECOVER@nih.gov inbox. Please place "MEDIA INQUIRY" in your subject line.